Immunotherapy Is Now First-line Therapy for Some Colorectal Cancers
Pembrolizumab is the first immunotherapy drug approved as a first-line treatment for patients with certain types of colorectal cancer that can be administered without initial chemotherapy.
Source: JAMA - Category: General Medicine Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Colorectal Cancer | General Medicine | Immunotherapy